RPL23AP72

Across TCGA pan-cancer cohorts, RPL23AP72 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RPL23AP72 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher RPL23AP72 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL23AP72 expression acts as an unfavorable survival marker, although some lineages such as UCS and PAAD show a favorable association.

CHOL, THYM, and ESCA are the cancer types where RPL23AP72 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	DFS	Tertile	All	0.045	0.486	.009	45	view →
THYM	OS	Tertile	All	0.824	0.986	.006	45	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
UCEC	DFS	Tertile	All	0.733	0.851	.007	36	view →
READ	OS	Tertile	IV	0.077	1.000	.014	27	view →
UCS	DFS	Tertile	IV	0.996	0.525	.018	18	view →
PAAD	OS	Tertile	All	0.578	0.307	.039	15	view →
CESC	DFS	Tertile	III,IV	0.106	0.432	.047	12	view →
SARC	DFS	Tertile	All	0.112	0.406	.028	12	view →
MESO	DFS	Tertile	IV	0.071	0.359	.009	9	view →
COAD	DFS	Tertile	IV	1.000	0.369	.028	9	view →
STAD	OS	Tertile	IV	0.380	0.700	.031	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RPL23AP72–CHOL (DFS)

Open the CHOL breakdown →